JACOBS LEVY EQUITY MANAGEMENT, INC

Position in ARCT — Arcturus Therapeutics Holdings Inc.

CIK 884414 FLORHAM PARK, NJ

Position in ARCT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,351,273

+$2,817,093 QoQ

Shares Held

647,511

+225.8% QoQ

Ownership

2.28%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#11

of 133 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 83% Shared 0% None 17%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. ARCT ranks #28 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	256,503	$159,939,880
2	RARE	Ultragenyx Pharmaceutical Inc.	2,939,719	$98,157,217
3	INCY	Incyte Corp	731,774	$82,953,900
4	CORT	Corcept Therapeutics Inc	695,532	$60,476,507
5	HALO	Halozyme Therapeutics, Inc.	322,377	$25,232,447
6	EXEL	Exelixis, Inc.	415,650	$22,615,516
7	AUPH	Aurinia Pharmaceuticals Inc.	1,231,516	$20,898,826
8	ALNY	Alnylam Pharmaceuticals, Inc.	60,986	$18,358,615

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,351,273	647,511	+225.8%	Shares	Sole	2026-08-14
2026-03-31	$1,534,180	198,728	-32.2%	Shares	Sole	2026-05-15
2025-12-31	$1,796,396	293,050	-4.1%	Shares	Sole	2026-02-13
2025-09-30	$5,633,295	305,659	-38.3%	Shares	Sole	2025-11-17
2025-06-30	$6,443,735	495,291	+243.6%	Shares	Sole	2025-08-14
2025-03-31	$1,526,453	144,141	+20.6%	Shares	Sole	2025-05-15
2024-12-31	$2,028,899	119,558	+19.9%	Shares	Sole	2025-02-14
2024-09-30	$2,314,013	99,699	-0.6%	Shares	Sole	2024-11-14
2024-06-30	$2,443,181	100,336	+4.6%	Shares	Sole	2024-08-14
2024-03-31	$3,239,353	95,924	+111.0%	Shares	Sole	2024-05-15
2023-12-31	$1,433,164	45,454	+387.4%	Shares	Sole	2024-02-14
2023-09-30	$238,279	9,326	-45.9%	Shares	Sole	2023-11-17
2023-06-30	$494,385	17,238	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.